CommunityRx-Kidney Health for Chronic Kidney Disease

This study is testing an intervention called CommunityRx-Kidney Health (CRx-K) to help people manage chronic kidney disease (CKD) in rural eastern North Carolina. CRx-K uses health technology to connect you with medical care, social support (like food or housing), and self-care resources (like exercise tips). You might be able to join if you are 18 or older, have CKD (stages 1-4), and have visited Goshen Medical Center in the last year. The study aims to see if CRx-K can reduce how often people need acute healthcare (like emergency room visits or hospital stays) over 12 months. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 634 participants. It is testing a behavioral intervention called CommunityRx-Kidney Health (CRx-K).
What's involved
Participants will receive brief education, a personalized community resource list, and support from a clinic navigator for 12 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months to measure acute healthcare utilization.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07237295

CommunityRx-Kidney Health

Recruiting
NAAges 18+InterventionalHealth services
University of North Carolina, Chapel Hill
~634 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:CommunityRx-Kidney Health

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acute healthcare utilization
Measured over 12 months
Chronic Kidney Disease (Stages 1-4)

NCT07237295

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Goshen Medical Center

    Beulaville, North Carolinastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Gaurav J Dave, MBBS, MPH, DrPH · PRINCIPAL_INVESTIGATOR · University of North Carolina, Chapel Hill
  • Abhijit V Kshirsagar, MD, MPH · PRINCIPAL_INVESTIGATOR · University of North Carolina, Chapel Hill
  • Stacy Tessler Lindau, MD, MA · PRINCIPAL_INVESTIGATOR · University of Chicago

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of chronic kidney disease defined as ≥1 ICD-10 CKD codes (excluding end-stage kidney disease) or CKD biomarkers (estimated glomerular filtration rate ≤ 60 ml/min, albuminuria ≥30 mg/24h)
At least one clinic visit at Goshen Medical Center in 12 months before enrollment

Exclusion

Limited life expectancy (e.g., advanced cancer, end-stage liver disease, hospice)
Active cancer treatment
Living in a skilled nursing facility
Dementia/other significant cognitive impairment/inability to participate in the informed consent process
  • Acute healthcare utilization12 months

    Acute healthcare utilization is measured as the sum of self-reported 911 calls, ambulance visits, emergency room visits, urgent care visits, and hospital admissions across the 12-month follow-up period.